William F. Peacock, MD

A panel of experts discuss their key takeaways and the future of treating opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss a multidisciplinary approach to treating patients with opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, share their thoughts on how to bring awareness to opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss managing adverse events that stem from using peripheral μ-opioid receptor antagonists to treat opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, consider potential patient preferences when choosing oral vs subcutaneous peripheral μ-opioid receptor antagonists.

A multidisciplinary panel shares individual experience with using oral peripherally acting μ-opioid receptor antagonists in managing opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, review the rationale for the use of μ-opioid receptor agonists for the treatment of opioid-induced constipation.

Experts in gastroenterology review the challenges associated with switching therapies during inpatient and outpatient care for patients with opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, discuss the multidisciplinary approaches to selecting therapies for patients with opioid-induced constipation.

A multidisciplinary panel shares practical approaches to treating patients with opioid-induced constipation and challenges with patient communication.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, reviews the position of pharmacies in providing patients with opioid-induced constipation with the necessary medication to decrease hospitalization and cost of medication.

Experts in gastroenterology discuss the quality of life and perspective of patients with opioid-induced constipation.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, explore the importance of early intervention and the overall challenges of ensuring that patients receive appropriate care for opioid-induced constipation.

A multidisciplinary panel discusses the presentation, frequency, and burden of opioid-induced constipation.

Dr William F. Peacock shares clinical pearls for the management of opioid-induced constipation.

An expert in emergency medicine shares his thoughts on the patient population inclusion criteria study designs when investigating treatment efficacy in patients with opioid-induced constipation.

William F. Peacock, MD, discusses real-world implications with opioid-induced constipation and comments on unmet needs in treating patients.

Dr William F. Peacock provides insight on the economic burden of opioid-induced constipation management strategies, highlighting the impact of hospitalization rates and prescription costs.

An expert in emergency medicine comments on the adverse event profile and concomitant use considerations with the administration of methylnaltrexone in patients suffering from opioid-induced constipation.

Dr William F. Peacock reviews key highlights and clinical implications from the post hoc analysis of a single dose of methylnaltrexone in patients suffering from opioid-induced constipation.

William F. Peacock, MD, provides an overview of opioid induced constipation and reviews the current treatment landscape and management strategies.